Insulin-like growth factor-I resistance.
Jain
S
S
Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Golde
D W
DW
Bailey
R
R
Geffner
M E
ME
D000349:Africa; D000818:Animals; D001827:Body Height / Q000208:ethnology / Q000235:genetics / Q000502:physiology*; D002884:Chromosomes, Human, Pair 15 / Q000235:genetics* / Q000502:physiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D005260:Female; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D007335:Insulin-Like Growth Factor II / Q000378:metabolism* / Q000502:physiology; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009748:Nutrition Disorders / Q000378:metabolism / Q000503:physiopathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017526:Receptor, IGF Type 1 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D017527:Receptor, IGF Type 2 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology
D017527:Receptor, IGF Type 2; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D017526:Receptor, IGF Type 1